Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)
Clinical trial NCT00243087 · COMPLETED
Trial details
- NCT number
- NCT00243087
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2008-08-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.